Acura Pharmaceuticals Provides Development Update on Its LIMITX(TM) Abuse Deterrent Technology
17 déc. 2015 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - December 17, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that's it is...
Acura Pharmaceuticals Receives 2015 Frost & Sullivan North American Opioid Oral Abuse Deterrence Technology Innovation Award
10 nov. 2015 06h00 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - November 10, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse-deterrent drugs, announced that it received the 2015...
Acura Pharmaceuticals Announces Third Quarter 2015 Financial Results
04 nov. 2015 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - November 04, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Host Third Quarter 2015 Financial Results Conference Call on November 5, 2015
28 oct. 2015 06h30 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - October 28, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company...
Acura Receives $2.5 Million Milestone Payment From Egalet Corporation
12 oct. 2015 06h30 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - October 12, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), today announced the receipt of a $2.5 million milestone payment from Egalet Corporation (NASDAQ: EGLT)...
Acura Pharmaceuticals Meets NASDAQ's Continuing Listing Requirement
16 sept. 2015 16h10 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - September 16, 2015) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) (the "Company"), announced that on September 15, 2015, the Company received a letter from the Listing...
Egalet Corporation Launches Acura Pharmaceuticals' OXAYDO(TM)
09 sept. 2015 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - September 09, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), today announced that Egalet Corporation (NASDAQ: EGLT) has commercially launched in the United States...
Acura Pharmaceuticals Announces 1-for-5 Reverse Stock Split
24 août 2015 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - August 24, 2015) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) (the "Company"), announced today that it will effect a 1-for-5 reverse stock split of its common stock. At a...
Acura Pharmaceuticals Announces Second Quarter 2015 Financial Results
03 août 2015 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - August 03, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call on August 4, 2015
27 juil. 2015 10h11 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - July 27, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company plans to...